Navigation Links
Mylan Receives Approval for Generic Version of Neurontin® Tablets
Date:6/4/2010

PITTSBURGH, June 4 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin® Tablets for the treatment of postherpetic neuralgia, a complication of shingles. The product will be distributed by Mylan Pharmaceuticals Inc.

Gabapentin Tablets had U.S. sales of approximately $174 million for the 12 months ending March 31, 2010, according to IMS Health.

Currently, Mylan has 140 ANDAs pending FDA approval representing $95.5 billion in annual brand sales, according to IMS Health. Forty of these pending ANDAs are potential first-to-file opportunities, representing 21 billion in annual brand sales, for the 12 months ending Dec. 31, 2009 according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Valtrex®
2. Mylan Launches Temazepam Capsules USP, 7.5 mg
3. Mylan Announces Completion of Senior Notes Offering
4. Mylan Announces Upsizing and Pricing of Senior Notes
5. Mylan Announces Proposed Senior Notes Private Placement
6. Mylan Receives Approval for Generic Version of Zyban(R)
7. Mylan Receives Approval for Generic Version of Flomax(R)
8. Mylan Schedules First Quarter 2010 Financial Results Conference Call and Live Webcast
9. Mylan Receives Approval for Generic Version of Actigall(R)
10. Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
11. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... 2017 Clarius Mobile Health, a digital ... scanners this week at the American Congress of ... San Diego, CA from ... the perfect tool for clinicians to easily confirm ... evaluate pregnancy-related complications like ectopic pregnancy and placenta ...
(Date:5/4/2017)... May 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it is teaming ... STI Technologies Limited to lower diabetes healthcare costs in ... innoviCares card, which is available throughout all provinces and ... will be eligible for additional savings when shopping for ...
(Date:5/4/2017)... BOTHELL, Wash. , May 4, 2017   ... a leading developer, manufacturer and marketer of proprietary clinical ... media ("BioLife" or the "Company"), today announced that ... released after market close on Thursday, May 11, 2017, ... and live webcast at 1:30 p.m. PT that afternoon. ...
Breaking Medicine Technology:
(Date:5/19/2017)... ... May 19, 2017 , ... In a continuous effort ... , a luxury online mattress company that specializes in natural and organic latex mattresses, ... grassroots autism organization) for every unique share their recent viral Facebook video ...
(Date:5/19/2017)... , ... May 19, 2017 , ... ... BioEnergy in an upcoming episode of Innovations with Ed Begley, Jr., airing fourth ... is the distributor of a clean, organic dietary supplement made from naturally occurring ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm of Brady/Callahan has ... Good Reasons To Hire An Experienced Personal Injury Attorney, " the article offers insight ... injury. As the article says. if someone is injured due to another person's ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... and retirement planning assistance to families and business owners in the region, is ... advocate for MS sufferers and their families. , Multiple sclerosis (MS) is a ...
(Date:5/19/2017)... ... May 19, 2017 , ... SyncDog, ... and speaking session at the 7th Annual ET6 Exchange (formerly M6 ... and digital transformation conference whose expressed purpose is to connect mobile technology end ...
Breaking Medicine News(10 mins):